Harriet Isom resumes & CV records
Resumes
Harriet Isom
Harriet Isom
Harriet Isom
Harriet Isom
Location:
United States
Harriet C Isom, 77Nokomis, FL
Harriet Isom Phones & Addresses
Nokomis, FL
1727 Ardry Way, Venice, FL 34292 941-4888759
Hummelstown, PA
Hershey, PA
Harrisburg, PA
Dauphin, PA
1059 Derry Woods Dr, Hummelstown, PA 17036 717-5333398
Work
Position:
Financial Professional
Education
Degree:
Associate degree or higher
Mentions for Harriet C Isom
Publications & IP owners
Us Patents
Method For Detecting Variant Hbv
US Patent:
6969583, Nov 29, 2005
Filed:
Feb 2, 2001
Appl. No.:
09/781891
Inventors:
William Delaney, IV - San Mateo CA, US
Stephen Alister Locarnini - St Kilda East, AU
Robert Yung Ming Chen - Flemmington, AU
Angeline Bartholomeusz - Carnegie, AU
Harriet Isom - Hummelstown PA, US
Stephen Alister Locarnini - St Kilda East, AU
Robert Yung Ming Chen - Flemmington, AU
Angeline Bartholomeusz - Carnegie, AU
Harriet Isom - Hummelstown PA, US
Assignee:
Melbourne Health - Parkville
The Penn State Research Foundation - University Park PA
The Penn State Research Foundation - University Park PA
International Classification:
C12N015/866
C12N015/63
C12N015/64
C12Q001/68
C12Q001/70
C12N015/63
C12N015/64
C12Q001/68
C12Q001/70
US Classification:
435 5, 435 6, 435 71, 4353201, 4352351, 435325, 435366, 435370, 435 74, 435 76, 435 691, 435455, 435456, 435236, 536 231, 536 2372, 530350
Abstract:
The present invention relates generally to an assay for detecting variant Hepatitis B viruses (HBVs) which exhibit altered sensitivity to agents. The variant HBVs are delivered to cells using a baculovirus vector. The altered sensitivity to an agent is in relation to the effects of the agent on one or more stages of infection, replication, assembly or release of virus or virus-like particles. The identification of variant HBVs with altered sensitivities to anti-HBV agents provides a means of monitoring cross resistance, or the development of new therapeutics effective against variant HBVs with altered sensitivities to other anti-HBV agents, as well as monitoring therapeutic protocols. The present invention further provides variant HBVs detected by the assay of the present invention and to components thereof as well as recombinant, chemical analogue, homologue and derivative forms of such components.
Methods And Compositions To Investigate Infection By Hepatitis B Virus And Agents To Prevent And Treat The Infection
US Patent:
6610471, Aug 26, 2003
Filed:
Sep 5, 2000
Appl. No.:
09/600731
Inventors:
Harriet C. Isom - Hershey PA
Assignee:
The Penn State Research Foundation - University Park PA
International Classification:
C12Q 170
US Classification:
435 5, 435 691, 435370, 436820
Abstract:
Methods and compositions that use the hepatitis B virus genome, and fragments or extensions, in a baculovirus vector, to develop anti-HBV agents and to drive high-level expression of a desired gene in a cell of hepatic origin.
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.